Insider Financial OTC part of an article on March
Post# of 30067
(Total Views: 596)
Posted On: 03/23/2020 11:34:28 AM
Insider Financial OTC part of an article on March 22nd
More exposure:
Viral Test Kits: Decision Diagnostics Corp. (OTCMKTS: DECN) is rolling out their GenViro! Covid-19 Rapid test kits. Some debate has been circulating over the weekend on the accuracy of serology tests …also Danaher Corp. (NYSE: DHR) who acquired Cepheid, the company in which the FDA just approved their fast result test kit with results in hours rather than days, should see a bump come Monday morning. AYTU BioScience (OTCMKTS: AYTU) and Todos Medical (OTCMKTS: TOMDF) both have a blood test with a 90% sensitivity than can be done between 2 to 10 minutes. Todos Medical has stated that its supplier can supply 300,000 test kits daily. The quicker these Chinese approved test kits get validated the more people that can be tested. They key is to pick the development team that can validate the test as quickly as possible. Based on the announcement Todos has a decisive lead in experience with Rao Mulpuri who is an expert in genomics and has commercialized a number of molecular diagnostics before.
More exposure:
Viral Test Kits: Decision Diagnostics Corp. (OTCMKTS: DECN) is rolling out their GenViro! Covid-19 Rapid test kits. Some debate has been circulating over the weekend on the accuracy of serology tests …also Danaher Corp. (NYSE: DHR) who acquired Cepheid, the company in which the FDA just approved their fast result test kit with results in hours rather than days, should see a bump come Monday morning. AYTU BioScience (OTCMKTS: AYTU) and Todos Medical (OTCMKTS: TOMDF) both have a blood test with a 90% sensitivity than can be done between 2 to 10 minutes. Todos Medical has stated that its supplier can supply 300,000 test kits daily. The quicker these Chinese approved test kits get validated the more people that can be tested. They key is to pick the development team that can validate the test as quickly as possible. Based on the announcement Todos has a decisive lead in experience with Rao Mulpuri who is an expert in genomics and has commercialized a number of molecular diagnostics before.
(2)
(0)